Investigates anti-NMDA antibody prevalence in first-episode psychosis, indicating low rates in a Chinese population.
Studies on the presence of anti-NMDA receptor antibodies were done primarily on the European population. This study investigates the prevalence of anti-NMDA antibodies among adult patients presenting with first-onset psychosis in an acute medical setting in the predominantly Chinese population of Hong Kong ( n = 109), and our results suggest that such prevalence is low in this population (1.8%), especially among patients with primary psychotic disorders (0%). Further studies are needed to explore the ethnic variation in anti-NMDA receptor positivity.
No takes yet. Share an insight, caveat, or question.
Chau et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: